Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArrow Explor. Regulatory News (AXL)

Share Price Information for Arrow Explor. (AXL)

Share Price is delayed by 15 minutes
Get Live Data
28.25    0.00 (0.00%)
Bid:
27.50
Ask:
29.00
Spread: 1.50 (5.455%)
Market Cap: £81.47m
AXL Live PriceLast checked at - London Stock Exchange

Intraday Arrow Explor. Share Chart

Arrow Announces AGM Voting Results

27 Sep 2024 07:00

RNS Number : 8761F
Arrow Exploration Corp.
27 September 2024
 

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

ARROW ANNOUNCES AGM VOTING RESULTS

CALGARY, September 27, 2024 - Arrow Exploration Corp. (AIM: AXL; TSXV: AXL) ("Arrow" or the "Company"), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to announce its AGM voting results.

Report in Respect of Voting Results Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations

The following sets forth a brief description of each matter voted upon at the annual general meeting (the "Meeting") of the holders of common shares of Arrow held on September 25, 2024 and the outcome of the vote:

Description of Matter

Outcome of Vote

Votes For

Votes Against or Withheld

1. Number of Directors

To set the number of directors at six (6).

Approved

32,483,567 99.74%

83,518

0.26%

2. Election of Directors

Marshall Abbott

Approved

 

32,436,651

99.60%

130,434

0.40%

Grant M. Carnie

Approved

 

32,536,651 99.91%

30,434

0.09%

Gage Jull

Approved

 

20,877,917 64.11%

11,689,168

35.89%

Ian Langley

Approved

 

32,536,651 99.91%

30,434

0.09%

Ravi Sharma

Approved

 

32,383,680 99.44%

183,405

0.56%

Anthony Zaidi

Approved

 

32,383,630 99.44%

183,455

0.56%

3. Appointment of Auditors

Appointment of Ernst & Young LLP as Auditors of the Corporation of the ensuing year and authorizing the Directors to fix their remuneration.

Approved

32,525,183 99.87%

41,902

0.13%

4. Approval and Amendment of Option Plan

To re-approve the Corporation's stock option plan and to approve certain amendments thereto as more particularly set out in the Information

Circular and Proxy Statement (collectively, the "Circular") of the Corporation dated August 7, 2024.

Approved

20,751,170 63.72%

11,815,915

36.28%

 

 

For further Information, contact:

Arrow Exploration

 

Marshall Abbott, CEO

+1 403 651 5995

Joe McFarlane, CFO

+1 403 818 1033

 

 

Canaccord Genuity (Nominated Advisor and Joint Broker)

 

Henry Fitzgerald-O'Connor

James Asensio

George Grainger

+44 (0)20 7523 8000

 

Auctus Advisors (Joint Broker)

 

Jonathan Wright

+44 (0)7711 627449

Rupert Holdsworth Hunt

 

 

Camarco (Financial PR)

 

Andrew Turner

+44 (0)20 3781 8331

Rebecca Waterworth

 

 

About Arrow Exploration Corp.

Arrow Exploration Corp. (operating in Colombia via a branch of its 100% owned subsidiary Carrao Energy S.A.) is a publicly traded company with a portfolio of premier Colombian oil assets that are underexploited, under-explored and offer high potential growth. The Company's business plan is to expand oil production from some of Colombia's most active basins, including the Llanos, Middle Magdalena Valley (MMV) and Putumayo Basin. The asset base is predominantly operated with high working interests, and the Brent-linked light oil pricing exposure combines with low royalties to yield attractive potential operating margins. Arrow's 50% interest in the Tapir Block is contingent on the assignment by Ecopetrol SA of such interest to Arrow. Arrow's seasoned team is led by a hands-on executive team supported by an experienced board. Arrow is listed on the AIM market of the London Stock Exchange and on TSX Venture Exchange under the symbol "AXL".

Forward-looking Statements

This news release contains certain statements or disclosures relating to Arrow that are based on the expectations of its management as well as assumptions made by and information currently available to Arrow which may constitute forward-looking statements or information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results or developments that Arrow anticipates or expects may, could or will occur in the future (in whole or in part) should be considered forward-looking statements. In some cases, forward-looking statements can be identified by the use of the words "continue", "expect", "opportunity", "plan", "potential" and "will" and similar expressions. The forward-looking statements contained in this news release reflect several material factors and expectations and assumptions of Arrow, including without limitation, Arrow's evaluation of the impacts of global pandemics, the potential of Arrow's Colombian and/or Canadian assets (or any of them individually), the prices of oil and/or natural gas, and Arrow's business plan to expand oil and gas production and achieve attractive potential operating margins. Arrow believes the expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations, and assumptions will prove to be correct.

The forward-looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUNOVRSWUKUAR
Date   Source Headline
27th May 20267:00 amRNSArrow Announces Q1 2026 Interim Results
26th May 20267:00 amRNSArrow Announces Exploration Well IC-1 Results
22nd May 20267:00 amRNS-RInvestor Presentation Via Investor Meet Company
13th May 20267:00 amRNSArrow Announces Exploration Well IC-1 Log Results
8th May 20267:00 amRNSArrow Announces Appraisal Well M-12 Results
5th May 20264:53 pmRNSTR-1: Notification of major holdings
29th Apr 20267:00 amRNSArrow Announces 2025 Year End and Q4 2025 Results
14th Apr 20265:32 pmRNSStandard form for notification of major holdings
1st Apr 20267:49 amRNSREPLACE - Arrow Appraisal Well M-11 Results
1st Apr 20267:00 amRNSArrow Announces Appraisal Well M-11 Results
25th Mar 20267:00 amRNSGrant and PDMR Exercise of Stock Options
20th Mar 20267:00 amRNSOperational Update and 2025 Year-End Reserves
2nd Mar 20267:00 amRNSArrow Announces Appraisal Wells M-9HZ, M-10 Result
28th Jan 20267:00 amRNSArrow Announces Appraisal Well M-8 Results
18th Dec 20257:00 amRNSArrow Announces Appraisal Well M-HZ7 Results
27th Nov 20257:00 amRNSArrow Announces Q3 2025 Interim Results
26th Nov 20257:00 amRNSARROW ANNOUNCES APPRAISAL WELL M-6 RESULTS
20th Nov 20257:00 amRNSAIM Rule 17 - Schedule 2(g) Update
12th Nov 20257:00 amRNSArrow Announces Exploration Well M-5 Results
9th Oct 20257:00 amRNSArrow Announces Grant of Stock Options
1st Oct 20257:00 amRNSArrow Announces Operational Update
25th Sep 20257:00 amRNSArrow Announces AGM Voting Results
9th Sep 20257:00 amRNSArrow Announces Operational Update
28th Aug 20257:00 amRNSArrow Announces Q2 2025 Interim Results
20th Aug 20257:00 amRNSArrow Announces Filing of AGM Materials
15th Jul 20257:00 amRNSOperational Update
9th Jul 20257:00 amRNSArrow Announces Resignation of Director
19th Jun 20257:00 amRNSPDMR Exercise and Grant of Options
13th Jun 20257:00 amRNSArrow Announces Normal Course Issuer Bid
30th May 20257:00 amRNSQ1 2025 Interim Results and Operational Update
29th Apr 20257:00 amRNSArrow Announces 2024 Year End and Q4 2024 Results
10th Apr 20257:00 amRNSOPERATIONAL UPDATE
13th Mar 20257:00 amRNS2024 Year-End Reserves Update
5th Feb 20257:00 amRNSArrow Announces Update on AB Wells
6th Jan 20257:00 amRNSArrow Announces Exploration Well AB-1 Results
17th Dec 20247:00 amRNSAB-1 Exploration Well Update
28th Nov 20247:00 amRNSQ3 2024 Interim Results
11th Nov 20247:00 amRNSFifth Ubaque Horizontal Well Results
27th Sep 20247:00 amRNSArrow Announces AGM Voting Results
23rd Sep 20247:00 amRNSFourth Ubaque Horizontal Well Results
12th Sep 20247:00 amRNSArrow Announces Grant of Stock Options
29th Aug 20247:00 amRNSThird Horizontal Well Results and Q2 2024 Results
21st Aug 20247:00 amRNSArrow Announces Filing of AGM Materials
14th Aug 20247:01 amRNSTR-1: Notification of major holdings
14th Aug 20247:00 amRNSTR-1: Notification of major holdings
31st Jul 20247:00 amRNSSecond Ubaque Horizontal Well Results
4th Jul 20247:00 amRNSPDMR Exercise of Options
21st Jun 20247:00 amRNSDirector/PDMR Shareholding
19th Jun 20247:00 amRNSFirst Ubaque Horizontal Well Results
4th Jun 20247:00 amRNSReplacement - Q1 2024 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.